Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.


UNLABELLED Hepatitis C virus (HCV) entry is a multiple-step process involving a number of host factors and hence represents a promising target for new antiviral drug development. In search of novel inhibitors of HCV infection, we found that a human apolipoprotein E (apoE) peptide, hEP, containing both a receptor binding fragment and a lipid binding fragment… (More)
DOI: 10.1002/hep.25665


7 Figures and Tables